





















This meeting is recommended for: investors, pharma investors, digital health companies. Preferred level of familiarity with the topic: high
Managing risks and maximising ROI is the new mantra of digital health investors. After a year of limited funding and cash inflows, digital health companies are resurfacing from a fundraising hiatus. How will they approach fundraising in 2024 and how will potential investors react in this precarious, albeit recovering, economic climate?
Join this HealthXL meeting and learn from industry experts about how to navigate the current investment landscape:
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.